Biomarker-Based Management of AKI: Fact or Fantasy?

Abstract	New biomarkers for acute kidney injury (AKI) have improved our understanding of the etiology and pathogenesis of AKI. Depending on their origin, function, and kinetic profile, biomarkers have a role in screening, diagnosis, prognostication, and monitoring of AKI. This offers opportunities to improve the management of AKI, but concerns and limitations remain. In this review, we summarize the current role of new AKI biomarkers in the management of AKI and outline some of the ongoing limitations and challenges.
Authors	Marlies Ostermann, Emma Karsten, Nuttha Lumlertgul
Journal	Nephron (Nephron) Vol. 146 Issue 3 Pg. 295-301 ( 2022) ISSN: 2235-3186 [Electronic] Switzerland
PMID	34515152 (Publication Type: Journal Article, Review)
Copyright	© 2021 The Author(s) Published by S. Karger AG, Basel.
Chemical References	Biomarkers
Topics	Acute Kidney Injury (diagnosis, therapy) Biomarkers Fantasy Female Humans Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!